Chronic Kidney Disease Trial, Recruiting NCT07059962 Sponsor: Bodyport Inc. Condition: Chronic Kidney Disease
Back to Chronic Kidney Disease

Chronic Kidney Disease Trial, Recruiting

NCT07059962
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are 21 years of age or older
  • People who can speak and read English, or people who can speak and read Spanish and have a caregiver or family member who speaks English and can help them
  • People who are able to stand on both bare feet without assistance
  • People who are currently receiving a specific type of kidney dialysis treatment at home called automated peritoneal dialysis for end-stage kidney disease
  • People whose dialysis is being monitored through a remote management system called the Vantive Sharesource Remote Patient Management Platform

Who may not be able to join:

  • People who are currently having, or are planning to have, a different type of dialysis called hemodialysis within the next 12 months
  • People whose doctors have estimated their life expectancy to be less than 12 months
  • People who are pregnant or are planning to become pregnant in the next 12 months
  • People who weigh more than 375 pounds (approximately 170 kilograms)
  • People who have a kidney transplant planned within the next 12 months
  • People who have an implanted neurostimulator device (a device surgically placed in the body that delivers electrical signals to nerves) (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 415-990-5415

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Bodyport Inc.
Registry
ClinicalTrials.gov
Start date
9 September 2025
Est. completion
1 June 2026

Where this trial is recruiting

🇨🇦 Canada 🇺🇸 United States

Primary endpoints

Sensitivity Analysis

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov